Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLP for Opioid Dose Reduction in SCI, Polytrauma, and Burn Injury
NCT03906721Phase 2Completed
- Sponsor
- Spaulding Rehabilitation Hospital
- Start
- Feb 2019
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in pain (2 arms), sponsored by Spaulding Rehabilitation Hospital. Primary endpoint: Morphine Milligram Equivalents at 6 days. Started Feb 2019; status: completed.
02
Conditions
pain
Beyond the preview
Go deeper on NCT03906721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03906721.